New Zealand markets close in 4 hours 5 minutes

MaaT Pharma SA (MAAT.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
9.46+0.06 (+0.64%)
At close: 02:24PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 109.06M
Enterprise value 98.83M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)47.95
Price/book (mrq)5.33
Enterprise value/revenue 44.36
Enterprise value/EBITDA -5.36

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 312.17%
S&P500 52-week change 325.38%
52-week high 39.90
52-week low 34.50
50-day moving average 38.94
200-day moving average 37.31

Share statistics

Avg vol (3-month) 31.6k
Avg vol (10-day) 3611
Shares outstanding 511.6M
Implied shares outstanding 611.6M
Float 82.23M
% held by insiders 132.37%
% held by institutions 150.04%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,342.12%

Management effectiveness

Return on assets (ttm)-28.44%
Return on equity (ttm)-83.41%

Income statement

Revenue (ttm)2.23M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)-9.20%
Gross profit (ttm)N/A
EBITDA -19.74M
Net income avi to common (ttm)-19.72M
Diluted EPS (ttm)-1.70
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.31M
Total cash per share (mrq)2.1
Total debt (mrq)14.07M
Total debt/equity (mrq)68.77%
Current ratio (mrq)2.78
Book value per share (mrq)1.77

Cash flow statement

Operating cash flow (ttm)-18.67M
Levered free cash flow (ttm)-11.1M